Valuation: Waters Corporation

Capitalization 31.72B 26.72B 24.37B 23.27B 43.2B 2,873B 44.88B 283B 113B 1,387B 119B 116B 4,848B P/E ratio 2025
35.3x
P/E ratio 2026 * 26.6x
Enterprise value 32.44B 27.33B 24.93B 23.8B 44.18B 2,938B 45.9B 290B 115B 1,419B 122B 119B 4,959B EV / Sales 2025
7.14x
EV / Sales 2026 * 5.65x
Free-Float
36.42%
Yield 2025 *
-
Yield 2026 * -
1 day+1.11%
1 week-15.19%
Current month-12.77%
1 month-17.76%
3 months-14.77%
6 months+10.17%
Current year-14.86%
1 week 305.35
Extreme 305.35
344.97
1 month 305.35
Extreme 305.35
401.1
Current year 305.35
Extreme 305.35
408.67
1 year 275.05
Extreme 275.05
414.15
3 years 231.9
Extreme 231.9
423.56
5 years 231.9
Extreme 231.9
428.22
10 years 118.74
Extreme 118.745
428.22
Manager TitleAgeSince
Chief Executive Officer 55 2020-08-31
Director of Finance/CFO 50 2021-05-11
Chief Tech/Sci/R&D Officer 48 2018-02-28
Director TitleAgeSince
Director/Board Member 72 2006-04-30
Chairman 68 2019-12-31
Director/Board Member 67 2018-08-31
Change 5d. change 1-year change 3-years change Capi.($)
+1.11%-15.19%-12.54%-4.70% 31.72B
-0.98%-7.00%-5.08%-11.66% 190B
+1.51%-0.47%-18.42%+101.52% 173B
-1.10%-1.86%+3.04%-17.04% 150B
+0.82%-2.02%-29.57%+58.06% 111B
+0.79%-1.74%-29.86%-20.76% 53.87B
-0.75%-3.61%-0.42%-0.94% 44.03B
+2.78%-7.02%+8.40%+18.06% 36.79B
+2.15%-0.38%-12.87%+10.65% 36.61B
+0.74%-2.91%-6.58%-17.79% 35.58B
Average +0.71%-3.82%-10.39%+11.54% 86.19B
Weighted average by Cap. +0.29%-2.95%-10.89%+21.22%

Financials

2025 2026 *
Net sales 3.16B 2.66B 2.43B 2.32B 4.31B 286B 4.47B 28.27B 11.22B 138B 11.86B 11.61B 483B 6.41B 5.4B 4.93B 4.7B 8.73B 581B 9.07B 57.31B 22.75B 280B 24.04B 23.55B 980B
Net income 674M 568M 518M 495M 919M 61.09B 954M 6.03B 2.39B 29.5B 2.53B 2.48B 103B 1.09B 915M 835M 797M 1.48B 98.35B 1.54B 9.71B 3.85B 47.5B 4.07B 3.99B 166B
Net Debt 723M 609M 555M 530M 984M 65.46B 1.02B 6.46B 2.56B 31.61B 2.71B 2.65B 110B 4.5B 3.79B 3.46B 3.3B 6.12B 407B 6.36B 40.19B 15.95B 197B 16.86B 16.51B 687B
Logo Waters Corporation
Waters Corporation specializes in the conception, the manufacturing and the marketing of analytical instruments. Net sales break down by activity as follows: - sale of instruments and analytical systems (62.3%): chromatographic analysis instruments (56% of net sales; instruments high performance liquid chromatography and mass spectrometry), chemistry consumables (30.6%; including columns chemical separation) and thermal analysis, rheometry and calorimetry instruments (13.4%); - services (37.7%): support services, training, etc. Net sales are distributed by market between pharmaceutical (58.1%), industrial (30.7%), academic institutions and governmental agencies (11.2%). Net sales are distributed geographically as follows: the United States (31.6%), Americas (6.2%), China (13.4%), Japan (5.3%), Asia (14%) and Europe (29.5%).
Employees
7,900
Date Price Change Volume
26-02-13 323.37 $ +1.11% 2,532,396
26-02-12 319.83 $ -2.85% 3,478,657
26-02-11 329.20 $ +0.67% 4,046,126
26-02-10 327.02 $ -0.34% 3,754,470
26-02-09 328.14 $ -13.94% 2,554,286
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
323.37USD
Average target price
402.71USD
Spread / Average Target
+24.54%

Quarterly revenue - Rate of surprise